Screener
Nuvation Bio NUVB EBIT
Discontinued — last reported Q2 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from Nuvation Bio’s reported figures.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
FAQ
- What is Nuvation Bio's EBIT?
- Nuvation Bio (NUVB) reported EBIT of -$51.04M in Q2 2026.
- How has Nuvation Bio's EBIT changed year-over-year?
- Nuvation Bio's EBIT increased by 19.7% year-over-year, from -$63.59M to -$51.04M.
- What is the long-term trend for Nuvation Bio's EBIT?
- Over 4 years (2021 to 2025), Nuvation Bio's EBIT has grown at a 22.9% compound annual growth rate (CAGR), from -$93.32M to -$213.06M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Nuvation Bio's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude